RxDoctor Payments Data
★ My doctorsLook up a doctor →

William Harwin

Medical Oncology · Fort Myers, FLNPI 1164413589

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (42.2%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 49 manufacturers reported payments, led by Daiichi Sankyo Inc. at 42.2% of the total. Reporting peaked in 2020 at $36,023 and has fallen 99.9% since, to $19 in 2024.

$60,570in general payments, 2019–2025

Across 220 payments — averaging $275.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Daiichi Sankyo Inc.$26K
  • Sanofi$9K
  • Tesaro, Inc.$7K
  • AstraZeneca$6K
  • Eisai Inc.$3K
  • Karyopharm Therapeutics Inc.$2K
  • plus $8K from 43 others
$2,692,656in research payments, 2019–2025

Across 213 payments — averaging $12,642 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Seagen Inc.$1.8M
  • Pfizer$919K

What the payments were for

  • Consulting fees$23,59639%
  • Speaking & faculty fees$25,54842%
  • Travel & lodging$5,3459%
  • Food & beverage$6,01510%
  • Education$670%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Daiichi Sankyo Inc.20$25,581
Sanofi18$9,084
Tesaro, Inc.7$7,112
AstraZeneca8$5,867
Eisai Inc.2$2,623
Karyopharm Therapeutics Inc.4$2,291
Beigene USA, Inc.1$1,650
E.r. Squibb & Sons, L.L.C.47$999
Ipsen Bioscience Inc.1$850
Janssen Scientific Affairs, LLC1$650
Bristol Myers Squibb23$523
Beigene, Ltd.1$450
Amgen8$312
Johnson & Johnson10$273
Incyte Corporation6$262
Gilead10$222
Merck8$192
Seagen Inc.2$171
ADC Therapeutics America, Inc.3$125
Genentech USA, Inc.6$118
Epizyme, Inc.1$117
Siemens Medical Solutions USA, Inc.1$110
Verastem, Inc.1$109
Array Biopharma Inc1$97
Amerisourcebergen Drug Corporation1$93
Cardinal Health 110 LLC1$83
Heron Therapeutics, Inc.1$77
GSK2$65
Novartis3$53
CTI Biopharma Corp.2$42
CSL Behring1$38
Ipsen Biopharmaceuticals, Inc1$37
Exelixis Inc.2$31
Regeneron Healthcare Solutions, Inc.1$26
Pharmacyclics LLC, An Abbvie Company1$23
Servier Pharmaceuticals LLC1$21
Morphosys, US Inc.1$20
Lilly USA, LLC1$20
Alnylam Pharmaceuticals Inc.1$18
Sanofi-aventis U.S. LLC1$18
Sobi, Inc1$17
Agios Pharmaceuticals, Inc.1$15
Sumitomo Pharma America, Inc.1$13
Helsinn Therapeutics (U.S.), Inc.1$13
Astellas Pharma US Inc1$13
Rigel Pharmaceuticals, Inc.1$12
Pfizer1$12
Partner Therapeutics, Inc.1$11
GE HealthCare1$9

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$60,570 in reported general payments places this provider in the 85th percentile of 507 medical oncology providers in Florida.

See all medical oncology providers in Florida →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Letrozole14$400

Paid to pharmacies, not to this prescriber.

Other medical oncology in Fort Myers

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →